Fluticasone propionate 250 mcg / salmeterol 50 mcg (salmeterol xinafoate 72.5 mcg) per ACTUAT Dry Powder Inhaler
RxNorm 1359859
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1359859 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: fluticasone propionate 250 mcg / salmeterol 50 mcg (salmeterol xinafoate 72.5 mcg) per ACTUAT Dry Powder Inhaler.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Fluticasone propionate 0.25 mg/ACTUAT / salmeterol 0.05 mg/ACTUAT Dry Powder Inhaler
(Atom ID: 12332479)
SY